Seattle, WA, United States of America

Ryo Kubota

This inventor holds 72 USPTO granted patents and 28 published patent applications and 3 EPO patents, primarily in Ophthalmic Technologies (CPC class C07C). Top assignees: Acucela Inc., University of Washington. Active years: 2007-2025.

USPTO Granted Patents = 72 

% Patents Active = 80.6

 

Average Co-Inventor Count = 4.4

ph-index = 17

Forward Citations = 615(Granted Patents)

Forward Citations (Not Self Cited) = 89(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Refractive Error
Optical Coherence Tomography
Myopia Treatment
Electronic Spectacles
Peripheral Defocus
Hydrogel Contact Lens
Retinal Projection
Diabetic Retinopathy
Asymmetric Projection
Axial Length Measurement
Mobile Imaging Systems
Flexible PCB
72 patents (USPTO):Explore Patents

Title: The Innovative Journey of Ryo Kubota

Introduction: Ryo Kubota, a pioneering inventor based in Seattle, WA, has made significant contributions to the field of healthcare through his groundbreaking innovations.

Latest Patents: Ryo Kubota holds several patents in the medical technology sector, focusing on advancements in diagnostic tools and treatment methods for various diseases.

Career Highlights: With a background in medicine and a passion for research, Ryo Kubota has led successful projects that have resulted in life-changing inventions, improving the quality of healthcare worldwide.

Collaborations: Throughout his career, Ryo Kubota has collaborated with leading researchers, healthcare professionals, and technology experts to bring his innovative ideas to life and make a lasting impact on the industry.

Conclusion: Ryo Kubota's dedication to innovation and his commitment to improving healthcare have solidified his reputation as a visionary inventor in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…